Woodline Partners LP Humacyte, Inc. Transaction History
Woodline Partners LP
- $17.6 Billion
- Q2 2025
A detailed history of Woodline Partners LP transactions in Humacyte, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 2,001,393 shares of HUMA stock, worth $3.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,001,393
Previous 3,950,000
49.33%
Holding current value
$3.6 Million
Previous $6.75 Million
38.08%
% of portfolio
0.02%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding HUMA
# of Institutions
171Shares Held
54.5MCall Options Held
1.1MPut Options Held
808K-
Black Rock Inc. New York, NY7.14MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$12.6 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$7.9 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT3.43MShares$6.17 Million0.42% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$5.31 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $185M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...